Prevalence of infection with hepatitis C virus in Venezuela, as assessed with an immuno-assay based on synthetic peptides

Annals of Tropical Medicine and Parasitology

Volumn 95, Issue 2, 2001, Pages 187-195

  Aguilar, M S ^a   Cosson, C ^a   Loureiro, C L ^a   Devesa, M ^a   Martinez J ^a   Villegas, L ^a   Flores, J ^a   Ludert, J E ^a   Alarcon de Noya B ^a   Noya, O ^a   Liprandi, F ^a   Pujol, F H ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY; SYNTHETIC PEPTIDE;

ACCURACY; ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; CROSS REACTION; ENZYME IMMUNOASSAY; FEMALE; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARASITE ISOLATION; PREVALENCE; RACE DIFFERENCE; RELIABILITY; SEROPREVALENCE; VENEZUELA;

ADOLESCENT; ADULT; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MASS SCREENING; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; PREGNANCY; PREVALENCE; REAGENT KITS, DIAGNOSTIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RURAL HEALTH; SENSITIVITY AND SPECIFICITY; SEROEPIDEMIOLOGIC STUDIES; URBAN HEALTH; VENEZUELA;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 17744376753     PISSN: 00034983     EISSN: None     Source Type: Journal    
DOI: 10.1080/00034980120042944     Document Type: Article

References (28)

1. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994
2. Global surveillance and control of hepatitis C
3. Polyclonal B-lymphocyte stimulation in human malaria and its association with ongoing parasitemia
4. Antigenic diversity of hepatitis B virus strains of genotype F in Amerindians and other population groups from Venezuela
5. Epidemiology of hepatitis C virus in western Venezuela: Lack of specific antibody in Indian communities
6. Serological survey of viral hepatitis agents among Yukpa Amerindian populations from western Venezuela. Absence of hepatitis C infection
7. Hepatitis viruses: Their role in human cancer
8. Reduced antibody reactivity to hepatitis C virus antigens in hepatitis B virus co-infected hemodialysis patients
9. Restricted isotypic antibody reactivity to hepatitis C virus synthetic peptides in immunocompromised patients
10. Infection by hepatitis virus among the indigenous populations of South America: A review of the problem
11. Hepatitis C virus: Epidemiology and transmission
12. Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein
13. Seroprevalence of hepatitis C antibody in Peru
14. Linear B-cell epitopes of the NS3-NS4-NS5 proteins of the hepatitis C virus as modeled with synthetic peptides
15. Immune response to an epitope of the NS4 protein of hepatitis C virus in HCV-related disorders
16. Genomic characterization of hepatitis C virus isolates from Argentina
17. HCV: Epidemiology, modes of transmission and prevention of spread
18. Determination of hepatitis C virus genotypes in Venezuela by restriction fragment length polymorphism
19. Lymphocyte polyclonal activation: A pitfall for vaccine design against infectious agents
20. Comparison of prevalence of anti-hepatitis C virus antibodies in different South American populations
21. Rational use of diagnostic tools in hepatitis C
22. Prevalence of hepatitis C virus in urban and rural populations of northeast Brazil - Pilot study
23. Concomitant high prevalence of hepatitis C virus antibodies and hepatitis B virus markers in a small village of the Amazon region, Mato Grosso state, Brazil
24. Hepatitis C virus prevalence among an immigrant community to the southern Amazon, Brazil
25. Prevalence of antibodies to hepatitis A, C, and E viruses in different groups in French Guiana
26. Hepatitis B and hepatitis delta virus infection in South America
27. Epidemiology of hepatitis C: Geographic differences and temporal trends
28. Characterization of a linear epitope in the nonstructural region 4 of hepatitis C virus with reactivity to seroconversion antibodies